Lucky No. 7
Frazier tailors seventh biotech fund to fit in LPs' $250-$400M sweet spot
In raising its seventh fund, Frazier Healthcare took the advice of LPs who suggested bigger is not always better. The fund closed last week at $377 million, overshooting its $300 million target but coming in well below the $600 million fund Frazier closed in 2007.
LPs are decreasing their venture
